Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer
Condition(s):Colorectal CancerLast Updated:February 9, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Colorectal CancerLast Updated:February 9, 2017Unknown status
Condition(s):Hepatitis B, ChronicLast Updated:May 2, 2018Completed
Condition(s):ANCA Associated Vasculitis; Microscopic Polyangiitis; Churg-Strauss Syndrome; Wegener GranulomatosisLast Updated:August 28, 2023Recruiting
Condition(s):HealthyLast Updated:November 19, 2020Completed
Condition(s):ANCA-associated Vasculitis; Granulomatosis With Polyangiitis; Microscopic Polyangiitis; Eosinophilic Granulomatosis With PolyangiitisLast Updated:March 14, 2023Completed
Condition(s):Hodgkin’s Lymphoma; Primary Mediastinal Large B-cell Lymphoma (PMBCL)Last Updated:January 30, 2024Active, not recruiting
Condition(s):Advanced Solid TumorLast Updated:March 12, 2024Recruiting
Condition(s):Mucopolysaccharidosis IILast Updated:March 5, 2024Recruiting
Condition(s):Advanced Solid TumorLast Updated:November 15, 2023Recruiting
Condition(s):Glioblastoma MultiformeLast Updated:April 14, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.